Deciphering the role of the GUT and tumor microbiome on ovarian cancer progression and resistance to chemotherapy
Active Project Grant Awarded Last action
- Award ID
- HT9425261E061
- Recipient
-
The Cleveland Clinic Foundation UEI TDGUJ1WA4UJ9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $700,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 13% complete
- Place of performance
- Cleveland, OH 44195, USA
Award details come from USAspending.gov.
About this award
The Defense Health Agency awarded The Cleveland Clinic Foundation $700,000 on May 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct research deciphering the role of the gut and tumor microbiome on ovarian cancer progression and resistance to chemotherapy. The recipient will perform the work in Cleveland, Ohio, over a four-year period ending April 30, 2030. The award is classified as a project grant, a standard assistance type within the Defense Health Agency's Military Medical Research and Development program, which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public. The program's typical awards range from $100,000 to $20 million depending on funding priorities and project scope.
Quick answers
Who received award HT9425261E061?
HT9425261E061 was awarded to The Cleveland Clinic Foundation by Defense Health Agency (Department of Defense) on May 1, 2026.
How much is award HT9425261E061 worth?
$700,000 has been obligated on HT9425261E061.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award